Free Trial

Medical Properties Trust (NYSE:MPT) Sees Large Volume Increase - What's Next?

Medical Properties Trust logo with Real Estate background
Image from MarketBeat Media, LLC.

Key Points

  • Trading volume surged 94% to about 16.85 million shares; MPT was reported down 5.4% in the session, last trading at $1.625.
  • Analyst sentiment is bearish: MarketBeat’s consensus rating is “Strong Sell”, with an average price target of $2.68. Recent downgrades included Wells Fargo, RBC and BNP Paribas Exane.
  • MPT reported quarterly EPS of $0.11, below the $0.13 consensus estimate, while revenue rose 5.3% year over year to $250.14 million.
  • MarketBeat previews top five stocks to own in December.

Medical Properties Trust, Inc. (NYSE:MPT - Get Free Report) saw unusually-strong trading volume on Monday. Approximately 16,848,490 shares were traded during trading, an increase of 94% from the average daily volume of 8,700,700 shares. The stock last traded at $1.6250 and had previously closed at $1.67.

Wall Street Analyst Weigh In

A number of research analysts have commented on the stock. Wells Fargo & Company reduced their price objective on shares of Medical Properties Trust from $5.00 to $3.80 and set an "underweight" rating on the stock in a research note on Tuesday, September 1st. Royal Bank Of Canada lowered Medical Properties Trust from a "sector perform" rating to an "underperform" rating and dropped their price target for the company from $4.50 to $2.00 in a research report on Friday, October 30th. Wall Street Zen downgraded Medical Properties Trust from a "hold" rating to a "sell" rating in a research note on Saturday. Weiss Ratings raised Medical Properties Trust from a "sell (d)" rating to a "sell (d+)" rating in a report on Monday, November 9th. Finally, BNP Paribas Exane downgraded Medical Properties Trust from an "outperform" rating to a "neutral" rating and set a $2.25 price objective for the company. in a research note on Tuesday, November 3rd. One investment analyst has rated the stock with a Hold rating and three have issued a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Strong Sell" and an average price target of $2.68.

View Our Latest Research Report on MPT

Medical Properties Trust Trading Down 5.4%

The firm has a market capitalization of $930.46 million, a P/E ratio of 3.85 and a beta of 1.51. The company has a quick ratio of 3.92, a current ratio of 3.92 and a debt-to-equity ratio of 2.00. The business's 50 day moving average is $2.98 and its two-hundred day moving average is $4.21.

Medical Properties Trust (NYSE:MPT - Get Free Report) last posted its quarterly earnings data on Thursday, October 29th. The company reported $0.11 EPS for the quarter, missing analysts' consensus estimates of $0.13 by ($0.02). Medical Properties Trust had a net margin of 24.14% and a return on equity of 5.45%. The company had revenue of $250.14 million for the quarter. The company's revenue for the quarter was up 5.3% on a year-over-year basis. Analysts expect that Medical Properties Trust, Inc. will post 0.51 EPS for the current year.

Hedge Funds Weigh In On Medical Properties Trust

Hedge funds and other institutional investors have recently modified their holdings of the stock. Continuum Advisory LLC purchased a new position in shares of Medical Properties Trust during the second quarter valued at $31,000. CoreCap Advisors LLC acquired a new stake in shares of Medical Properties Trust during the third quarter worth approximately $27,000. Nykredit A S purchased a new position in Medical Properties Trust during the second quarter valued at approximately $41,000. NFSG Corp acquired a new stake in shares of Medical Properties Trust during the 3rd quarter valued at $34,000. Finally, Frank Rimerman Advisors LLC purchased a new position in Medical Properties Trust in the third quarter valued at about $35,000. Institutional investors and hedge funds own 71.79% of the company's stock.

About Medical Properties Trust

(Get Free Report)

Medical Properties Trust is a real estate investment trust that owns and invests in healthcare facilities, with a primary focus on hospitals. The company leases its properties to healthcare operators and may provide financing related to the acquisition or development of medical facilities. Founded in 2003, Medical Properties Trust has built a portfolio of properties serving acute-care, behavioral health, rehabilitation and other healthcare needs. Its investments have included facilities in the United States and international markets.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Medical Properties Trust Right Now?

Before you consider Medical Properties Trust, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Medical Properties Trust wasn't on the list.

While Medical Properties Trust currently has a Strong Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines